Aug
15
2022
Jul
26
2022
SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
Jul
25
2022
Jun
13
2022
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
Jun
01
2022
May
12
2022
Apr
21
2022
Apr
12
2022
Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiovascular risk test
Mar
29
2022
Mar
21
2022
SomaLogic to provide 210 million protein measurements to EPIC researchers to better understand and predict cancer development
Displaying 1 - 10 of 19